Undesirable taste is an important problem for patient compliance. Several oral
pharmaceuticals and bulking agents have disagreeable and bitter-tasting components. The …

The aim of the study was to taste mask ciprofloxacin (CP) by using ion-exchange resins
(IERs) followed by sustain release of CP by forming interpenetrating polymer network (IPN) …

Objective: The objective was to evaluate taste masking of azithromycin (AZI) by ion
exchange resins (IERs) and the formation of covalent semi interpenetrating polymer network …

Context: Masking of bitter taste of drug for better patient compliance. Objective: The objective
of this research was to mask the bitter taste of Chlorpheniramine maleate using cation …

Objective The purpose of the present study was to prepare a clonidine hydrochloride (CH)
sustained-release suspension. Methods The processes involved in the drug formulation …

The objective of the present work was to evaluate and characterize a pediatric-friendly
formulation of a bitter tasting drug, oseltamivir phosphate (drug). Amberlite IRP64 (resin) …

Metformin hydrochloride is an oral antidiabetic biguinide agent, used in the management of
non-insulin-dependent (type-2) diabetes mellitus. The purpose of present work was to …

The purpose of this research was to mask the intensely bitter taste of tinidazole (TNZ) and to
formulate a palatable liquid formulation of the taste-masked drug, by novel Ion Exchange …

An attempt was made to sustain the release of metformin HCl as well as to mask the bitter
taste by complexation technique using strong cation-exchange resins, indion 244 and indion …

Bitter taste of ofloxacin, a broad spectrum bactericidal agent, is masked and orally
disintegrating tablets were formulated. The bitter taste is masked by forming complex …